Itau Unibanco Holding S.A. Intra Cellular Therapies, Inc. Transaction History

Itau Unibanco Holding S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$64.76 - $79.84 $3,238 - $3,992	50 New	50 $3,000
Q4 2022 Feb 09, 2023	SELL	$44.07 - $54.45 $440 - $544	-10 Reduced 6.21%	151 $7,000
Q2 2022 Aug 15, 2022	BUY	$43.0 - $65.64 $1,892 - $2,888	44 Added 37.61%	161 $9,000
Q1 2022 May 16, 2022	BUY	$38.74 - $62.09 $193 - $310	5 Added 4.46%	117 $7,000
Q4 2021 Feb 14, 2022	BUY	$35.2 - $53.42 $3,942 - $5,983	112 New	112 $6,000

378

84.7M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.87B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.